Health4 months ago
Sanofi Acquires Dynavax for $2.2 Billion, Boosting Vaccine Portfolio
Sanofi has announced its acquisition of Dynavax Technologies for $15.50 per share, a deal that values the biotechnology company at approximately $2.2 billion. This purchase represents...
